PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. a.mangia@tin.it.\', \'Veterans Health Administration, Office of Academic Affiliations, UC Davis, School of Medicine, Sacramento, CA, USA.\', \'Department of Hepato-Gastroenterology, Hospital Saint Joseph, Marseille, France.\', \'Academic Department of Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.\', \'Division of Liver Disease, Department of Medicine, Institute for Liver Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.\', \'Division of Infectious Diseases, Department of Medicine, John Hopkins School of Medicine, Baltimore, MD, USA.\', \'Gilead Sciences Europe Ltd, Stockley Park, UK.\', \'Department of Gastroenterology and Hepatology, CHU Pontevedra and IIS Galicia Sur, Pontevedra, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12325-021-01636-7
?:doi
?:hasPublicationType
?:journal
  • Advances in therapy
is ?:pmid of
?:pmid
?:pmid
  • 33590446
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.075
?:rankingScore_hIndex
  • 51
is ?:relation_isRelatedTo_publication of
?:title
  • Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33590446>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33590446>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all